Hebbar Sudarshan 4

Accession 0001209191-23-020678

CIK 0001534133other

View on SEC.gov Company Profile

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 8:48 PM ET

Size

43.5 KB

Accession

0001209191-23-020678

Insider Transaction Report

Form 4

Period: 2023-03-20

CalciMedica, Inc. /DE/CALC

Hebbar Sudarshan

Chief Medical Officer

Transactions

Award
Employee Stock Option (right to buy)
2023-03-20+22,777→ 22,777 total
Exercise: $2.44Exp: 2028-08-01→ Common Stock (22,777 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+8,640→ 8,640 total
Exercise: $2.44Exp: 2029-04-24→ Common Stock (8,640 underlying)
Award
Employee Stock Option (Right to Buy)
2023-03-20+2,524→ 2,524 total
Exercise: $6.60Exp: 2040-01-23→ Common Stock (2,524 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+24,968→ 24,968 total
Exercise: $6.60Exp: 2030-06-29→ Common Stock (24,968 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+9,774→ 9,774 total
Exercise: $7.99Exp: 2031-04-27→ Common Stock (9,774 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+9,774→ 9,774 total
Exercise: $7.99Exp: 2031-06-30→ Common Stock (9,774 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+838→ 838 total
Exercise: $10.42Exp: 2032-08-30→ Common Stock (838 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+1,954→ 1,954 total
Exercise: $10.42Exp: 2032-08-30→ Common Stock (1,954 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+6,352→ 6,352 total
Exercise: $10.42Exp: 2032-08-30→ Common Stock (6,352 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+23,836→ 23,836 total
Exercise: $17.34Exp: 2033-03-19→ Common Stock (23,836 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+7,381→ 7,381 total
Exercise: $17.34Exp: 2023-03-19→ Common Stock (7,381 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+11,761→ 11,761 total
Exercise: $1.74Exp: 2026-02-10→ Common Stock (11,761 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+11,778→ 11,778 total
Exercise: $6.60Exp: 2030-06-29→ Common Stock (11,778 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+18,782→ 18,782 total
Exercise: $7.99Exp: 2031-04-27→ Common Stock (18,782 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+2,880→ 2,880 total
Exercise: $19.45Exp: 2032-08-01→ Common Stock (2,880 underlying)
Award
Employee Stock Option (right to buy)
2023-03-20+3,108→ 3,108 total
Exercise: $17.34Exp: 2023-03-19→ Common Stock (3,108 underlying)

Footnotes (22)

[F1]Immediately exercisable.
[F10]25% of the shares subject to the option vested on January 1, 2021 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter.
[F11]Received in exchange for a stock option to acquire 408,982 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F12]Beginning on February 22, 2021, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.
[F13]Received in exchange for a stock option to acquire 339,404 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F14]Received in exchange for a stock option to acquire 652,174 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F15]Received in exchange for a stock option to acquire 100,000 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F16]Received in exchange for a stock option to acquire 29,117 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F17]Received in exchange for a stock option to acquire 67,873 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F18]Received in exchange for a stock option to acquire 220,588 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F19]Beginning on November 22, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.
[F2]Received in exchange for a stock option to acquire 408,402 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.
[F20]Received in exchange for a stock option to acquire 827,673 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F21]Received in exchange for a stock option to acquire 256,287 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F22]Received in exchange for a stock option to acquire 107,928 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F3]Received in exchange for a stock option to acquire 790,880 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F4]Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock.
[F5]Received in exchange for a stock option to acquire 300,000 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F6]25% of the shares subject to the option vested on April 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter.
[F7]Received in exchange for a stock option to acquire 87,658 shares of common stock of CalciMedica pursuant to the Merger Agreement.
[F8]25% of the shares subject to the option vested on June 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter.
[F9]Received in exchange for a stock option to acquire 866,952 shares of common stock of CalciMedica pursuant to the Merger Agreement.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CalciMedica, Inc. /DE/

CIK 0001534133

→

Entity typeother

Related Parties

filerCIK 0001968793

Filing Metadata

Form type: 4
Filed: Mar 21, 8:00 PM ET
Accepted: Mar 22, 8:48 PM ET
Size: 43.5 KB

View on SEC.gov